Taro Pharmaceutical Industries Ltd (TARO.N)

TARO.N on New York Stock Exchange

104.97USD
17 Apr 2014
Price Change (% chg)

$0.06 (+0.06%)
Prev Close
$104.91
Open
$104.91
Day's High
$105.00
Day's Low
$104.73
Volume
1,095
Avg. Vol
7,428
52-wk High
$121.32
52-wk Low
$53.58

TARO.N

Chart for TARO.N

About

Taro Pharmaceutical Industries Ltd. is a science-based pharmaceutical company. The Company develops manufactures, and markets prescription and over-the-counter (OTC) pharmaceutical products, primarily in the United States, Canada and Israel. The Company also develops and manufactures active pharmaceutical ingredients (APIs),... (more)

Overall

Beta: 0.49
Market Cap (Mil.): $4,698.71
Shares Outstanding (Mil.): 44.79
Dividend: --
Yield (%): --

Financials

Search Stocks

Sun Pharma says seeks to enter Japan generics market

MUMBAI - Sun Pharmaceutical Industries Ltd, India's biggest drugmaker by market value, is looking for partnerships or acquisitions to enter Japan, an especially lucrative market for manufacturers of low-cost drugs, a senior executive said.

06 Mar 2014

Sun Pharma gains on Taro's share buyback offer

Reuters Market Eye - Sun Pharmaceutical Industries gains 1 percent after unit Taro Pharmaceutical Industries announced the start of a tender offer to buy back up to $200 million of its ordinary shares.

26 Nov 2013

MARKET EYE-India's Sun Pharma gains on Taro's share buyback offer

* India's Sun Pharmaceutical Industries Ltd gains 1 percent after unit Taro Pharmaceutical Industries announced the start of a tender offer to buy back up to $200 million of its ordinary shares. * If the offer is fully subscribed, the number of Taro shares to be purchased in the offer represents approximately 4.6 to 5.3 percent of the unit's total outstanding shares. * Sun Pharma's stake in Taro will go up to more than 69 percent from 66 percent should the buyback be fully subscribed. (abhi

26 Nov 2013

BRIEF-Bluemountain Capital Management and Iszo Capital file lawsuit against Taro Pharmaceutical Industries

Nov 21 - BlueMountain Capital Management: * Bluemountain Capital Management and Iszo Capital file lawsuit against Taro

22 Nov 2013

Sun Pharma gains; unit Taro beats July-Sept estimates

Reuters Markete Eye - Sun Pharmaceutical Industries Ltd gains 2.8 percent after its unit Taro Pharmaceutical Industries Ltd operational earnings beat some analysts estimates.

13 Nov 2013

MARKET EYE-Sun Pharma surges; unit Taro beats July-Sept analysts' estimates

* India's Sun Pharmaceutical Industries Ltd gains 3 percent after its unit Taro Pharmaceutical Industries Ltd operational earnings beat some analysts estimates. * Taro's quarterly earnings per share came at $2.15 while sales rose 27.5 percent to $205.3 million. * Analysts say a price hike in certain product categories by Taro led to the operating earnings beat while also boosting outlook for Sun Pharmaceutical's earnings results later in the day. (abhishek.vishnoi@thomsonreuters.com /; abhis

13 Nov 2013

Earnings vs. Estimates

Search Stocks